Maturation in vitro of human oocytes from unstimulated cycles: selection of the optimal day for ovum retrieval based on follicular size.
The potential use of immature oocytes for in-vitro fertilization (IVF) requires the conditions for successful maturation to be defined. This study focused on the day of oocyte retrieval. The selection of a dominant follicle may induce endocrine changes in the remaining cohort that may be detrimental to their subsequent fertilization and embryonic development. Natural cycles in volunteer donors were followed by measurement of serum oestradiol and by vaginal ultrasound, starting on day 3 of the cycle. Cycles were randomly allocated to one of two groups: group 1 (n = 10), in which follicles were aspirated before the leading follicle was 10 mm in diameter; and group 2 (n = 9), in which follicles were aspirated when a dominant follicle was clearly visible with diameter >10 mm. Oocytes were cultured in vitro to metaphase II (MII) stage, donated, and inseminated by intracytoplasmic sperm injection (ICSI) with husband's spermatozoa. Those that became fertilized within 24 h were further co-cultured in autologous endometrial epithelial cells up to the blastocyst stage, and cryopreserved. There was a significantly (P < 0.05) increased rate of oocyte retrieval in group 1 (70.8% of aspirated follicles) compared with group 2 (50.5%). Maturation to MII and fertilization were similar between the groups. However, development to blastocyst stage was significantly (P < 0.05) higher in group 1 embryos (56.5%) compared with group 2 (35.7%). There was a positive correlation (r2 = 0.1978) between the appearance of the cumulus cells and the ability to develop to blastocyst stage when both parameters were analysed in group 1, whereas no such correlation was found in group 2. In conclusion, our data suggest the importance of retrieving immature oocytes before follicular selection, and define the conditions for the first stage in the use of immature oocytes. Further stages must be defined before this technique can be used clinically.
Instituto Valenciano de Infertilidad and Department of Paediatrics, Obstetrics andGynaecology, Valencia University School of Medicine, Valencia, Spain.
A C
AC
Cobo
A
A
Requena
F
F
Neuspiller
M
M
Aragon s
A
A
Mercader
J
J
Navarro
C
C
Simón
J
J
Remohí
A
A
Pellicer
D000328:Adult; D002454:Cell Differentiation; D005314:Embryonic and Fetal Development; D005260:Female; D005307:Fertilization in Vitro; D005498:Follicular Phase; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D018587:Oocyte Donation / Q000379:methods*; D009865:Oocytes / Q000166:cytology / Q000254:growth & development*; D006080:Ovarian Follicle / Q000033:anatomy & histology*; D011446:Prospective Studies; D013997:Time Factors